<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">MicroRNA-24-3p regulates Hodgkin&apos;s lymphoma cell proliferation, migration and invasion by targeting DEDD</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jing</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kai</forename><surname>Yin</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Neurosurgery and 3 Hematopathology</orgName>
								<orgName type="institution">The First Affiliated Hospital of Zhengzhou University</orgName>
								<address>
									<postCode>450052</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xianping</forename><surname>Lv</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Qiankun</forename><surname>Yang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ming</forename><surname>Shao</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Xin</forename><surname>Liu</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Hui</forename><surname>Sun</surname></persName>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Department of Hematopathology</orgName>
								<orgName type="institution">The First Affiliated Hospital of Zhengzhou University</orgName>
								<address>
									<addrLine>1 Jianshe East Road</addrLine>
									<postCode>450052</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">MicroRNA-24-3p regulates Hodgkin&apos;s lymphoma cell proliferation, migration and invasion by targeting DEDD</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">2392063F128986D59E1122D9F0EF2B6B</idno>
					<idno type="DOI">10.3892/ol.2018.9599</idno>
					<note type="submission">Received April 10, 2018; Accepted October 9, 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:43+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>microRNA-24-3p</term>
					<term>Hodgkin&apos;s lymphoma</term>
					<term>proliferation</term>
					<term>migration</term>
					<term>invasion</term>
					<term>DEDD This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Hodgkin's lymphoma (HL) is a common hematologic tumor, and the incidence is increasing.</s><s>At present, it is considered that miRNAs are closely related to HL. Substantial attention has been paid to the effects of miRNA on the pathophysiological process of HL.</s><s>This study was focused on the potential role of miR-24-3p in HL by targeting DEDD.</s><s>The reverse transcription-quantitative PCR (RT-qPCR) results demonstrated that miR-24-3p expression was highly elevated and DEDD expression reduced inversely in HL tissues compared to adjacent tissues.</s><s>According to the results of CKK-8 assays, miR-24-3p was able to accelerate HL cell proliferation.</s><s>In addition, the results of the Transwell assays also indicated that miR-24-3p promoted the invasion and migration abilities of HL cells.</s><s>Moreover, the results demonstrated that miR-24-3p inhibited DEDD expression.</s><s>Hence, the present study revealed that miR-24-3p could accelerate HL development through inhibiting DEDD.</s></p><p><s>Tissue specimens.</s><s>We collected the HL patients' tonsil tissue samples and matched normal tissues from the First Affiliated</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Hodgkin's lymphoma (HL) is a common lymphatic tumor, and the incidence rate by year of HL new cases range from three to four per 100,000 western individuals <ref type="bibr" target="#b0">(1)</ref>.</s><s>HL is an malignant tumor derived from B cells <ref type="bibr" target="#b1">(2)</ref>.</s><s>As it is hard to diagnose advanced HL, and the pathophysiological mechanisms of HL remain unknown, approximately 20% of the newly diagnosed cases die from HL <ref type="bibr" target="#b2">(3)</ref>.</s><s>Consequently, more effective treatments to increase HL survival rates need to be developed.</s><s>At the same time, understanding of the mechanisms of HL development is required.</s><s>Studies of factors associated with HL, such as genes and miRNAs, are also important.</s><s>miRNAs are 19-23 nucleotides in length.</s><s>As a subgroup of non-coding miRNAs, they play a role in regulating post-transcriptionally via targeting mRNA 3'UTR, causing their degradation or suppressing mRNA translation <ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref>.</s><s>An increasing number of studies have emerged, providing evidence that various miRNAs can exert oncogenic or tumor suppressive functions <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b7">8)</ref>.</s><s>For example, miR-148a suppresses migration and invasion of breast cancer <ref type="bibr" target="#b8">(9)</ref>.</s><s>miRNA-29b suppresses tumor angiogenesis, invasion, and metastasis <ref type="bibr" target="#b9">(10)</ref>.</s><s>miR-24-3p was proven to be involved in multiple kinds of tumors, including HL <ref type="bibr" target="#b10">(11)</ref>, head and neck squamous cell cancer <ref type="bibr" target="#b11">(12)</ref>, and bladder carcinoma <ref type="bibr" target="#b12">(13)</ref>.</s><s>However, the function of miR-24-3p in mediating HL invasion and migration remains largely elusive.</s></p><p><s>The death effector domain-containing protein (DEDD) has a relevance to different kinds of physiological processes, including cell mitosis, cycle and apoptosis <ref type="bibr" target="#b13">(14)</ref>.</s><s>Studies have shown that DEDD may be used as a potential therapeutic target and prognostic marker to cure metastasis of carcinoma <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref>.</s><s>However, the effects of DEDD on regulating HL have not yet been reported.</s><s>To better understand the anti-metastatic functions and mechanisms of DEDD in HL, the present study investigated the DEDD expression levels in HL tissues and cell lines.</s><s>At the same time, the correlation between miR-24-3p and DEDD in HL was analyzed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell cultures. HL cell lines [L1236 (CSC-C0538, Creative</head><p><s>Bioarray) and L428 (ws101345, ATCC)] were cultured in RPMI-1640 medium (Cellgro; Corning, Inc., Corning, NY, USA) in an atmosphere with 5% CO 2 at 37˚C.</s><s>The medium contained penicillin/streptomycin, 5% L428, 10% L1236 as well as 10% fetal bovine serum (FBS) (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA).</s></p><p><s>Germinal center (GC)-B cells were sorted from tonsil tissue samples of three HL donors aged between 3 and 10 years.</s><s>Two of the three GC-B cells were purified &gt;98% from human tonsil tissues on the basis of the CD20 + lgD -CD38 + expression, as previously described.</s><s>The third sample was magnetic-activated cell sorting purified &gt;95% based on expression of IgD -CD138 -CD3 -CD10 + .</s><s>Written informed consents were obtained for the use of the tonsil samples from the parents of the children.</s></p><p><s>Hospital of Zhengzhou University (Zhengzhou, China) between 2015 and 2017.</s><s>The obtained tissues were snap-frozen at -80˚C.</s><s>The parents of the HL patients provided written informed consent.</s><s>The present study obtained approval from the Ethics Committee of the First Affiliated Hospital of Zhengzhou University.</s></p><p><s>Cell transfection.</s><s>Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc., Carlsbad, CA, USA) was used to transfect miR-24-3p mimics or inhibitor as well as overexpression vector of DEDD into HL cells.</s><s>Plasmids were transfected into HL cell lines by X-tremeGENE HP DNA Transfection Reagent (Roche Diagnostics, Basel, Switzerland).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reverse transcription-quantitative PCR (RT-qPCR).</head><p><s>The TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) was used to isolate the total RNA from HL tissues, adjacent normal tissues and cultured L1236 and L428 cells respectively according to the manufacturer's protocol.</s><s>The reverse transcription reaction was then conducted to synthesize cDNAs using M-MLV Reverse Transcriptase reagent kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA).</s><s>RT-qPCR was conducted by Bio-Rad CFX96™ Real-Time PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA, USA) with the SYBR-Green kit (Takara Bio, Inc., Otsu, Japan) using specific primers (Table <ref type="table">I</ref>).</s><s>The conditions for PCR were as follows: 95˚C for 5 min, 40 cycles of denaturation at 95˚C (15 sec), 50˚C (30 sec) and 72˚C (30 sec).</s><s>The miR-24-3p expression was normalized to U6 while the DEDD expression was normalized to GAPDH.</s><s>The 2 -ΔΔCq method (17) was used to calculate the relative expression levels of genes.</s></p><p><s>Western blotting.</s><s>HL cells were lysed by chilled RIPA lysis buffer (9803; Cell Signaling Technology, Inc., Danvers, MA, USA) which contained phenylmethylsulfonyl fluoride protease inhibitor.</s><s>The lysates were put onto ice for half an hour, then centrifuged at 14,000 x g at 4˚C for 15 min.</s><s>The BCA Protein Assay kit (Thermo Fisher Scientific, Inc.) was applied to detect the protein concentration according to the manufacturer's protocol.</s><s>A total of 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate the proteins and then the separated proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane which was incubated at 4˚C overnight with primary antibodies diluted in 5% milk.</s><s>The primary antibodies were as follows: rabbit polyclonal antibodies against DEDD (dilution, 1:1,000; cat.</s><s>no.</s><s>ab203655; Abcam, Cambridge, MA, USA) and GAPDH (dilution, 1:1,000, cat.</s><s>no.</s><s>ab37168; Abcam).</s><s>A secondary incubation step was performed with appropriate secondary antibody for 1 h at room temperature.</s><s>The proteins were detected by a chemiluminescence method.</s><s>GAPDH (Abcam) was used as an internal loading control.</s></p><p><s>Cell Counting kit-8 (CCK-8).</s><s>The cell proliferation ability of HL cells was observed using CCK-8 (Beyotime Institute of Biotechnology, Haimen, China).</s><s>HL cells with different transfections were seeded and cultured in 96-well plates for 0, 12, 24, 48 and 72 h, respectively, adding 10 µl CCK-8 reagent into the 96-well plates.</s><s>At 2 h after being cultured at 37˚C, the absorbance of HL cells in different groups at 450 nm was detected by a microplate reader (BioTeke, Winooski, VT, USA).</s></p><p><s>Transwell assays.</s><s>The migration and invasion abilities of the treated HL cell lines were assessed by Transwell assays.</s><s>For the migration assay, the treated cells (1x10 5 cells/well) were seeded in the top chambers, and RPMI-1640 medium containing 20% FBS was seeded into the bottom chambers, being incubated at 37˚C for 24 h with 5% CO 2 .</s><s>After that, the migratory cells were fixed, stained and counted.</s><s>The difference between the migration and invasion assay was that Matrigel (BD Biosciences, Franklin Lakes, NJ, USA) was added into the wells.</s></p><p><s>Luciferase reporter assays.</s><s>The treated HL cells were co-transfected with luciferase reporter plasmids which contained wild-type or mutant 3'UTRs of DEDD and miR-24-3p by Lipofectamine 2000.</s><s>At 48 h after transfection, the Dual-Luciferase Reporter Assay kit (Promega Corp., Madison, WI, USA) was used to perform the luciferase reporter assays.</s><s>Statistical analysis.</s><s>All the above experiments were performed 3 times.</s><s>The statistical analysis was evaluated by the GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, CA, USA) together with SPSS 18.0 version (SPSS, Inc.</s><s>Chicago, IL, USA).</s><s>Student's t test and one way ANOVA followed by Tukey's post hoc test were used to analyze two or multiple groups, respectively.</s><s>Statistically significant difference was set at P&lt;0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>miR-24-3p expression is upregulated and DEDD expression is downregulated in HL.</head><p><s>To evaluate miR-24-3p and DEDD expression levels in HL, we collected HL tissues and matched normal tissues from 30 HL patients, and then measured DEDD expression as well as miR-24-3p expression.</s><s>The results of RT-qPCR revealed that the miR-24-3p expression in HL tissues was significantly increased in contrast with that in the normal control tonsil tissues (Fig. <ref type="figure" target="#fig_1">1A and B</ref>, P&lt;0.01).</s><s>Moreover, we found that the miR-24-3p expression level in GC-B cells was decreased compared with that in HL cells miR-24-3p accelerates HL cell proliferation.</s><s>The HL cells (L1236 and L428) transfected with mimics or inhibitor of miR-24-3p were used for detecting the role of miR-24-3p in HL cell proliferation.</s><s>The results of RT-qPCR assays demonstrated that the miR-24-3p mimic expression was high in L1236 and L428 cells (Fig. <ref type="figure" target="#fig_2">2A</ref> and B, P&lt;0.001 and &lt;0.01).</s><s>Subsequently, the CCK-8 assay was conducted to observe HL cell proliferation ability, and the results demonstrated that miR-24-3p promoted L1236 cell (Fig. <ref type="figure" target="#fig_2">2C</ref>) and L428 cell (Fig. <ref type="figure" target="#fig_2">2D</ref>) proliferation.</s></p><p><s>miR-24-3p accelerates HL cell invasion and migration.</s><s>We studied cell invasion and migration abilities in HL cells which were transfected with mimics or inhibitor of miR-24-3p.</s><s>The results showed that there was a significant rise in the invasion of L136 and L428 cells transfected with mimics of miR-24-3p in contrast with the HL cells transfected with control mimics (P&lt;0.001).</s><s>On the contrary, the Transwell results demonstrated a significant decrease in the invasion of L136 and L428 cells transfected with inhibitor of miR-24-3p compared to the control group (Fig. <ref type="figure" target="#fig_3">3A and C, P&lt;0</ref>.001 and &lt;0.01).</s><s>In addition, according to the Transwell assays, the results also demonstrated that miR-24-3p promoted HL migration ability (Fig. <ref type="figure" target="#fig_3">3B and D, P&lt;0</ref>.001 and &lt;0.01).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>miR-24-3p suppresses DEDD gene transcription in HL by targeting its 3'UTR.</head><p><s>To investigate whether DEDD expression had relevance to miR-24-3p expression and to better understand the function of miR-24-3p in HL, TargetScan was used to find the target sites in the DEDD sequence of miR-24-3p (Fig. <ref type="figure" target="#fig_4">4A</ref>).</s></p><p><s>We measured the DEDD 3'UTR luciferase activities by luciferase reporter gene assays.</s><s>We co-transfected mimics of miR-24-3p and wild-type DEDD 3'UTR vector or mutant DEDD 3'UTR vector into HL cells to observe whether DEDD was the target of miR-24-3p, and then detected the role of miR-24-3p in regulating the mRNA and protein expression of DEDD.</s><s>The results showed that there was a significant of fluorescence activity in both L1236 (P&lt;0.01) and L428 (P&lt;0.001) cells co-transfected with the wild-type DEDD 3'UTR vector and miR-24-3p in contrast with the control group, however, between cells co-transfected with the mutant DEDD 3'UTR vector and miR-24-3p and the control group, there was no significant difference (Fig. <ref type="figure" target="#fig_4">4B and C</ref>).</s><s>The results  of RT-qPCR and western blotting both demonstrated that miR-24-3p could inhibit DEDD expression in L1236 and L428 cells (Fig. <ref type="figure" target="#fig_4">4D and E, P&lt;0</ref>.001 and &lt;0.01).</s></p><p><s>The role of DEDD in regulating miR-24-3p effects in HL cell migration and invasion.</s><s>We investigated whether DEDD was required in regulating miR-24-3p functions of promoting HL cell invasion and migration.</s><s>Overexpression vector of DEDD and miR-24-3p mimics were co-transfected into L1236 and L428 cells using RT-qPCR to detect the DEDD mRNA expression, the results are shown in Fig. <ref type="figure">5A</ref>.</s><s>Then, we detected the migration and invasion in HL cells which were co-transfected with overexpression vector of DEDD and miR-24-3p mimics using Transwell assay.</s><s>The results revealed that the overexpression of DEDD markedly reversed miR-24-3p-mediated promotion of cell migration and invasion in HL cells (Fig. <ref type="figure">5B-D, P&lt;0</ref>.01).</s><s>Collectively, these data suggested that DEDD may reverse partial function of miR-24-3p in HL cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>HL is a particular B-cell malignancy, accounting for a large percentage of lymphomas <ref type="bibr" target="#b17">(18)</ref>.</s><s>Despite significant advances in the treatment of HL, existing treatments fail to cure 10-20% of HL patients.</s><s>Similarly, 10-20% of HL patients may be over-treated.</s><s>So, reliable predictive biomarkers for HL patients who need intensive therapy remain a challenge.</s><s>Such biomarkers could also provide insight into the biology of HL.</s></p><p><s>Several studies have indicated that different kinds of miRNAs are involved in different kinds of biological activities, for instance, cell proliferation, migration, metastasis and inflammation <ref type="bibr" target="#b18">(19,</ref><ref type="bibr" target="#b19">20)</ref>.</s><s>Multiple studies have found that many different miRNAs play an important role in the development of HL.</s><s>For example, miR-124a methylation is associated with aggressive HL disease (21); miR-374b can suppress cell proliferation and promote cell apoptosis by inhibiting AKT1 and Wnt-16 in T-cell lymphoblastic lymphoma <ref type="bibr" target="#b21">(22)</ref>; miR-9 methylation is a common event in HL and participated in HL pathogenesis <ref type="bibr" target="#b22">(23)</ref>; overexpression of miR-155 and inhibition of its target NIAM enhance cell growth in HL <ref type="bibr" target="#b23">(24)</ref>.</s><s>miR-24-3p is one of the most studied miRNAs in different kinds of tumors.</s><s>Over the past decade, increasing evidence has indicated that dysregulation of miRNAs makes contributions to various aspects of tumorigenesis process.</s><s>miR-24-3p is a master regulator in gene regulation and is related to diverse human disease <ref type="bibr" target="#b24">(25)</ref>.</s><s>Several other studies also revealed an oncogenic role for miR-24-3p in other types of cancer, for instance, miR-24-3p has been proved to promote glioma cell proliferation by targeting MXI1 (26); miR-24-3p represses small cell lung carcinoma VP16-DDP chemoresistance through ATG4A <ref type="bibr" target="#b26">(27)</ref>.</s><s>However, as far as we know, there have been no previous studies which report the mechanism of miR-24-3p in HL.</s><s>To explore the functional relevance of miR-24-3p in HL, we compared its expression level in HL tissues to that in paracarcinoma tissues.</s><s>The results demonstrated that the miR-24-3p expression level in HL tissues was higher than that in paracarcinoma tissues.</s><s>In addition, it also indicated that miR-24-3p could promote HL cell proliferation, invasion and migration through DEDD.</s></p><p><s>present study provides evidence that miR-24-3p is involved in regulating HL cell proliferation, invasion and migration.</s><s>At the same time, miR-24-3p expression was increased and that of DEDD expression was decreased in HL tissues.</s><s>Moreover, miR-24-3p was able to suppress the gene transcription of DEDD.</s><s>Hence, the present study demonstrated that miR-24-3p promoted HL progression via suppressing DEDD.</s><s>Thus, it is suggested that miR-24-3p may be a key potential therapeutic target for the treatment of HL.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Table I.</s><s>Primer sequences for RT-qPCR.Primers Sequences miRNA-24-3p F 5'-AAC ACA CCT ATT CAA GGA TTC A-3' R 5'-CCC ATT CAG CAG GAA CAG AAA-3' U6 F 5'-CTC GCT TCG GCA GCA CA-3' R 5'-AAC GCT TCA CGA ATT TGC GT-3' DEDD F 5'-TCC CCA GCC CTC TAA AAC AG-3' R 5'-CCG CAG TCT GAT GTC ACA TG-3' GAPDH F 5'-TGC ACC ACC AAC TGC TTA GC-3' R 5'-GGC ATG GAC TGT GGT CAT GAG-3' RT-qPCR, reverse transcription-quantitative PCR; U6: snRNA, small nuclear RNA; DEDD: death effector domain-containing protein; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; F, forward; R, reverse.</s><s>(L1236 and L428) (Fig. 1C, P&lt;0.001).</s><s>The DEDD expression in HL tissues was significantly decreased compared to normal tonsil tissues (Fig. 1D, P&lt;0.01).</s><s>Furthermore, similar results were found in GC-B and HL cells (L1236 and L428) (Fig. 1E, P&lt;0.01).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>miR-24-3p expression is elevated and DEDD expression is reduced in HL tissues and cell lines.</s><s>(A) The miR-24-3p expression in HL tissues and matched normal tissues of 30 HL patients were detected by RT-qPCR.</s><s>(B) RT-qPCR was performed to measure the miR-24-3p expression in HL tissues (n=30) and matched normal tissues (n=30).</s><s>(C) miR-24-3p expression in HL L1236 and L428 cells was measured by RT-qPCR.</s><s>(D) The DEDD expression in human HL tissues (n=30) and matched normal tissues (n=30) was detected by RT-qPCR.</s><s>(E) The DEDD expression was measured using RT-qPCR in HL cells.</s><s>** P&lt;0.01, *** P&lt;0.001.</s><s>HL, Hodgkin's lymphoma; RT-qPCR, reverse transcription-quantitative PCR.</s></p></div></figDesc><graphic coords="3,43.42,57.33,508.44,365.24" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. miR-24-3p accelerates HL cell proliferation.</s><s>(A and B) The miR-24-3p expression in transfected (A) L1236 and (B) L428 cells were measured using RT-qPCR.</s><s>(C and D) The CCK-8 assay was conducted to investigate proliferation of transfected (C) L1236 and (D) L428 cells at 0, 12, 24, 48 and 72 h.</s><s>** P&lt;0.01, *** P&lt;0.001.</s><s>HL, Hodgkin's lymphoma; RT-qPCR, reverse transcription-quantitative PCR; CCK-8, Cell Counting kit-8.</s></p></div></figDesc><graphic coords="4,123.96,57.83,347.36,287.67" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. miR-24-3p accelerates HL cell invasion and migration.</s><s>(A) The invasion and (B) the migration cell numbers of L1236 and L428 were counted.</s><s>(C) Cell invasion was detected by the Transwell assay in transfected L1236 and L428 cells.</s><s>(D) The Transwell assay was conducted to detect cell migration in transfected L1236 and L428 cells.</s><s>** P&lt;0.01, *** P&lt;0.001.</s><s>HL, Hodgkin's lymphoma.</s></p></div></figDesc><graphic coords="4,98.40,408.47,398.47,282.91" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4.</s><s>The gene transcription of DEDD in HL was inhibited by miR-24-3p.</s><s>(A) TargetScan was applied to predict the target site of miR-24-3p in the DEDD sequence.</s><s>(B and C) The luciferase reporter gene assays were performed to detect the fluorescence activities of the DEDD 3'UTR in (B) L1236 and (C) L428 cells which were co-transfected with wild-type DEDD 3'UTR or mutational type DEDD 3'UTR and miR-24-3p, respectively.</s><s>(D) The DEDD mRNA expression in transfected L1236 and L428 cells was determined using RT-qPCR.</s><s>(E) The DEDD protein expression was evaluated in transfected L1236 and L428 cells by western blotting.</s><s>** P&lt;0.01, *** P&lt;0.001.</s><s>HL, Hodgkin's lymphoma; RT-qPCR, reverse transcription-quantitative PCR.</s></p></div></figDesc><graphic coords="5,111.37,57.68,372.53,363.54" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="6,75.06,56.69,445.16,337.32" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>Not applicable.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>No funding was received.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>JW drafted the manuscript.</s><s>JW, KY and XLv were mainly devoted to cell culture.</s><s>JW, QY and MS performed RT-qPCR.</s><s>XLi and HS were responsible for western blotting.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>The study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Zhengzhou, China).</s><s>Signed informed consent was obtained from the parents of the patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient consent for publication</head><p><s>Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The authors declare that they have no competing interests.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Gibcus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Harms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Schakel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Blokzijl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Möller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Poppema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kroesen</forename><surname>Bj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Van Den Berg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neoplasia</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="167" to="176" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Vardiman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Biol Interact</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="16" to="20" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Micro-RNA (miRNA) profile in Hodgkin lymphoma: Association between clinical and pathological variables</title>
		<author>
			<persName><forename type="first">S</forename><surname>Paydas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Acikalin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ergin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Celik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yavuz</forename></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tanriverdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Oncol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page">34</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Epigenetics and genetics. MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Kasinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Slack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="849" to="864" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A parsimonious model for gene regulation by miRNAs</title>
		<author>
			<persName><forename type="first">S</forename><surname>Djuranovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nahvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page" from="550" to="553" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">MicroRNAs in human cancer</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Farazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Hoell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Morozov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tuschl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">774</biblScope>
			<biblScope unit="page" from="1" to="20" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Role of microRNAs in endocrine cancer metastasis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Lima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Gomes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Santos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">456</biblScope>
			<biblScope unit="page" from="62" to="75" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Differential role of microRNAs in the pathogenesis and treatment of esophageal cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hemmatzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mohammadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Musavishenas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Baradaran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed Pharmacother</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="509" to="519" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1425" to="1432" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Y</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Zhuang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1729" to="1740" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">miR-24-3p is overexpressed in Hodgkin lymphoma and protects Hodgkin and Reed-Sternberg cells from apoptosis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kluiver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rutgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abdul</forename><surname>Razak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Terpstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Plaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Nolte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Diepstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="1343" to="1355" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5</title>
		<author>
			<persName><forename type="first">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Future Oncol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="2701" to="2712" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD</title>
		<author>
			<persName><forename type="first">G</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Dou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1123" to="1131" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">DEDD decreases Smad3 activity, promotes tumor cell apoptosis and inhibits proliferation</title>
		<author>
			<persName><forename type="first">F</forename><surname>Hua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">X</forename><surname>Lü</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">W</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Yao Xue Xue Bao</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="680" to="685" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>In Chinese</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Microenvironment-dependent cues trigger miRNA-regulated feedback loop to facilitate the EMT/MET switch</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Carstens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lovisa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kalluri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="1458" to="1460" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">DEDD, a novel tumor repressor, reverses epithelial-mesenchymal transition by activating selective autophagy</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">W</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autophagy</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1675" to="1676" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Livak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Schmittgen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="402" to="408" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The influence of marital status on the survival of patients with Hodgkin lymphoma</title>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="51016" to="51023" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Paris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ngo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Frazier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Killary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mathy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="404" to="409" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Pt B</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The role of microRNAs in the tumorigenesis of ovarian cancer</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Leva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Croce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Oncol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">153</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Methylation of miR124a-1, miR124a-2, and miR124a-3 in Hodgkin lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ben Dhiab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ziadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ksiaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Louhichi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Gacem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Zineb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Amara</forename><forename type="middle">K</forename><surname>Hachana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Trimeche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1963" to="1971" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16</title>
		<author>
			<persName><forename type="first">D</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="4881" to="4891" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Investigation of miR9-1, miR9-2 and miR9-3 methylation in Hodgkin lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ben Dhiab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ziadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Louhichi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Gacem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ksiaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Trimeche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathobiology</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="195" to="202" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma</title>
		<author>
			<persName><forename type="first">I</forename><surname>Slezak-Prochazka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kluiver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Smigielska-Czepiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kortman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Winkle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rutgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diepstra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="2391" to="2400" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases</title>
		<author>
			<persName><forename type="first">R</forename><surname>Chhabra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dubey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Saini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cancer</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">232</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1</title>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Oncol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="757" to="766" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A</title>
		<author>
			<persName><forename type="first">B</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wang</forename><forename type="middle">R</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="317" to="331" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
